Member Info for F1Driver

In short order before a licensing deal takes it through the roof.

Everything is lining up nicely.

Re rate has only just begun.

$110 Billion market.

$4bn in sales is conservative for a highly disruptive drug. When licensed to a major pharma it will be much more.

Progressing discussions means discussions were already underway.

Predicted $4bn in annual sales!!!

"significant interest from leading Biopharmaceutical companies and we are progressing discussions as we move to establish global licensing agreements"

At an event with those very companies. Discussions ongoing for months already.

The advances made by ImmuPharma with the P140 program, particularly in the latter part of 2024, have led to significant interest from leading Biopharmaceutical companies and we are progressing discussions as we move to establish global licensing agreements.

There have been eleven $1bn+ licensing deals for immunology assets across the BioPharma industry from 2023 to late September 2024. The current trend suggests that Immunology and Autoimmune drug assets are becoming very highly sought by the leading BioPharma companies.

There are also warrants at much higher double digits idiot. Move a long. No one cares if ypu sold. 4 posts - sure you bought thursday

It shouldnt per se. Posting as seen.

Https://x.com/TheIronMan2023/status/1878596292722745528

"Massive interest in Immupharma at the JPMorgan Event"

Reported.

Follow the crumbs or in this case the breadloafs!! Ill keep tabs on X and media over the weekend.

MASSSIVE!!

The advances made by ImmuPharma with the P140 program, particularly in the latter part of 2024, have led to significant interest from leading Biopharmaceutical companies and we are progressing discussions as we move to establish global licensing agreements.

There have been eleven $1bn+ licensing deals for immunology assets across the BioPharma industry from 2023 to late September 2024. The current trend suggests that Immunology and Autoimmune drug assets are becoming very highly sought by the leading BioPharma companies.

We could see a deal this month. Remember the big guys have had visibility since last year May at the least.

News yday wont have been new to them, the event likely a catalyst and behind the scenes conversations.

Less than £15M mcap is ludicrously cheap, Im expecting a fast outcome to a deal or TO.

Potential $4bn in sales, but with a Major and their distribution could be significantly more.

MASSIVE!!!

Appvie has annual sales of $13.3bn. They are one the main leaders in the space. With a hugely disruptive prpduct we would be ripe for a straight takeover in the billions or a huge licensing and royalty agreement.

Try 30-50p+

ENET is a dog of a share. No contacts, highly misleading leadership (liars) and about to likely go into Admin. Please stop trying to make people lose money

1. $100bn+ market disruption

2. Event imminent where the largest players in the market will be.

3. JP Morgan invited little old IMM to attend

4. Licensing agreements with royalties could be in the billions of $

5. Massively undervalued relative to peers at a similar stage (hundreds of millions in mcap)

Looking forward to this re-rating!!

Wrong board.

1. $100bn+ market disruption

2. Event imminent where the largest players in the market will be.

3. JP Morgan invited little old IMM to attend

4. Licensing agreements with royalties could be in the billions of $

5. Massively undervalued relative to peers at a similar stage (hundreds of millions in mcap)

Looking forward to this re-rating!!

Your price calcs are way off notready